Arterial Inflammation and E-Cigarettes

University of California, Los Angeles (UCLA)

Status: Completed

Conditions: Arterial Inflammation

Treatments: Other: No drug or device, only a test. The test is called a PET/CT

Study type: Interventional

Funder types: Other

Identifiers

NCT02734888

15-000552

Details and patient eligibility

About

Arterial inflammation will be compared using PET scanning in 3 groups: 1) Non-smokers, 2) Tobacco cigarette smokers, 3) Electronic cigarette users.

Full description

Qualified participants will undergo a singe PET/CT to detect arterial inflammation.

Enrollment: 30 patients

Sex: All

Ages: 21 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Healthy

• Nonsmokers OR
• Daily e-cigarette user OR
• Daily tobacco cigarette smoker

Exclusion criteria

• Cardiac disease
• Respiratory Disease
• Diabetes mellitus

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 3 patient groups

Healthy control

Other group

Description:

Will undergo PET scan as a "negative control"

Treatment:

Other: No drug or device, only a test. The test is called a PET/CT

Tobacco cigarette smoker

Other group

Description:

Will undergo PET scan as a "positive control"

Treatment:

Other: No drug or device, only a test. The test is called a PET/CT

E-cigarette user

Other group

Description:

Will undergo PET scan

Treatment:

Other: No drug or device, only a test. The test is called a PET/CT